We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Serological cytokine signature in paediatric patients with inflammatory bowel disease impacts diagnosis.
- Authors
Tatsuki, Maiko; Hatori, Reiko; Nakazawa, Tomoko; Ishige, Takashi; Hara, Tomoko; Kagimoto, Seiichi; Tomomasa, Takeshi; Arakawa, Hirokazu; Takizawa, Takumi
- Abstract
Endoscopy is a central tool for diagnosing and evaluating paediatric inflammatory bowel diseases (PIBD), but is too invasive to be frequently repeated in young children. Furthermore, it is challenging to distinguish Crohn's disease (CD) from ulcerative colitis (UC) endoscopically. This study aimed to determine biomarkers useful for the diagnosis of PIBD. Cytokines, chemokines, and growth factors were quantified in the sera of 15 patients with CD or UC, at disease onset prior to treatment, and 26 age-matched controls. Correlation of cytokine levels with the paediatric CD activity index (PCDAI) and the paediatric UC activity index (PUCAI) was analysed. Interleukin (IL)-6, IL-13, IL-7, and vascular endothelial growth factor were higher in the CD group than in the UC group. The receiver operating characteristic curve analysis showed that IL-7 was a putative biomarker for distinguishing CD from UC (area under the curve: 0.94). Granulocyte–macrophage colony-stimulating factor was associated with PCDAI, and an IL-1 receptor antagonist, IL-6, and macrophage inflammatory protein-1β were associated with PUCAI. These findings indicate significant differences in cytokine signatures among patients with new-onset PIBD, which may improve accuracy in diagnosing PIBD.
- Subjects
CYTOKINES; INFLAMMATORY bowel diseases; CHILD patients; CROHN'S disease; ULCERATIVE colitis; CHEMOKINES
- Publication
Scientific Reports, 2020, Vol 10, Issue 1, pN.PAG
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-020-71503-y